C3a-derived peptide (AllergyFight)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameC3a-derived peptide (AllergyFight)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMast cell degranulation inhibitors
TargetsUpdating
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAllergyFight Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergyFight Ltd
Active IndicationsN/A
Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A